Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
Omkar Speciality Approves Sale of Two Industrial Plots Totaling 8,393 Sq. Mtrs. in Badlapur
Omkar Speciality Chemicals has approved the sale of two industrial land plots situated at MIDC Industrial Area, Badlapur, District Thane. The properties include Plot No. F-09 (2,519 sq. mtrs.) and Plot No. F-10 (5,874 sq. mtrs.), totaling 8,393 sq. mtrs. Financial terms, including sale consideration and buyer details, were not disclosed in the filing. The company stated it will make further disclosures as sale transactions progress.
medium confidence
What changedThe Board granted formal approval to monetize two industrial land parcels located at MIDC Badlapur, Thane.
Why it mattersMonetization of 8,393 sq. mtrs. of industrial real estate could provide a liquidity boost relative to the company's modest market cap of Rs 7 Cr, though deal valuation is currently undisclosed.
Plot F-09 Area: 2519 Sq. Mtrs.Plot F-10 Area: 5874 Sq. Mtrs.Total Land Area: 8393 Sq. Mtrs.Sale Consideration: not disclosed
📅 Short termMarket focus will remain on the execution timeline and exact cash realization figures once binding agreements are finalized.
📈 Long termAsset monetization could streamline operations or deleverage the balance sheet, but structural impact depends heavily on the realized proceeds.
⚠ Risk flags
No financial valuation or consideration disclosed
Execution and buyer completion risks
👀 What to Watch
Track subsequent filings for the final transaction consideration, buyer details, and how net proceeds will be deployed (e.g., debt reduction or working capital).
Q1 FY27 Net Loss at Rs 36.07 Lakhs on Nil Operational Revenue Post-Resolution
Omkar Speciality Chemicals reported zero revenue from operations for the quarter ended June 30, 2026, identical to the nil revenue in the corresponding quarter of the previous year. The company posted a net loss of Rs 36.07 Lakhs for the quarter, marginally narrower than the Rs 40.98 Lakhs loss in Q1 FY26. Total expenses stood at Rs 36.07 Lakhs, consisting mainly of depreciation (Rs 21.73 Lakhs) and other expenses (Rs 13.50 Lakhs). Statutory auditors highlighted the ongoing implementation of the NCLT-approved Resolution Plan dated July 31, 2025, noting that lender dues have been settled as the company prepares to restart commercial operations.
high confidence
What changedOmkar Speciality Chemicals submitted its Q1 FY27 financial results reporting continued operational inactivity with a Rs 36.07 Lakhs net loss alongside status notes on its post-NCLT debt settlement.
Why it mattersConfirms that while balance sheet debt settlement under the NCLT resolution plan has been executed, the business has yet to recommence core commercial manufacturing operations.
Revenue from Operations: NilNet Loss (Q1 FY27): Rs 36.07 LakhsDepreciation Expense: Rs 21.73 LakhsPaid-up Equity Capital: Rs 2,057.80 Lakhs
📅 Short termSubdued near-term performance as fixed overheads and depreciation will continue to generate quarterly losses until commercial operations restart.
📈 Long termLong-term viability is entirely contingent on successfully recommissioning manufacturing assets and generating sustained chemical sales post-insolvency.
⚠ Risk flags
Zero operational revenue generated during the quarter
Continued quarterly losses eroding net worth
Operational execution risks in restarting manufacturing facilities post-insolvency
👀 What to Watch
Monitor upcoming filings for updates on the actual resumption of commercial manufacturing operations and the revival of operational revenue streams.
Omkar Speciality reports ₹1.58 Cr Net Loss in FY26; ₹23.42 Cr infused via Resolution Plan
Omkar Speciality Chemicals has officially implemented its NCLT-approved resolution plan with Kshitij Polyline Limited as the successful applicant. For FY26, the company reported a net loss of ₹1.58 crore on negligible revenue of ₹0.82 lakhs, as manufacturing operations remain suspended. The resolution applicant has infused ₹23.42 crore into the company as of March 31, 2026, to facilitate revival and debt settlement. Despite negative other equity of ₹1.85 crore, the management is proceeding on a 'going concern' basis following the equity restructuring and fund infusion.
high confidence
What changedThe company has emerged from the Corporate Insolvency Resolution Process (CIRP) with a new promoter (Kshitij Polyline) and a restructured balance sheet.
Why it mattersThis represents a total reset for the company; while the debt has been addressed via the resolution plan, the business is currently non-operational and requires a successful restart to generate value.
Net Loss (FY26): ₹158.88 LakhsRevenue (FY26): ₹0.82 LakhsFund Infusion by Applicant: ₹2,342.13 LakhsInfusion vs Market Cap: 334.5%Negative Other Equity: ₹185.33 Lakhs
📅 Short termThe stock may remain volatile as the market digests the formalization of the resolution plan and the current lack of operational revenue.
📈 Long termThe long-term viability depends entirely on the new management's ability to restart the 5 manufacturing units and regain its historical market position in niche specialty chemicals.
⚠ Risk flags
Suspended manufacturing operations
Negative equity position
History of insolvency and payment delays
Significant reliance on the Resolution Applicant for funding
👀 What to Watch
Investors should closely monitor the timeline for the recommencement of manufacturing operations and the company's ability to scale revenue from the current near-zero base.
Board Meeting on Aug 7 to Approve Pending Financials for FY23, FY24, and FY25
Omkar Speciality Chemicals has scheduled a board meeting for August 7, 2026, to approve a multi-year backlog of financial results covering FY23, FY24, and FY25. The company was previously under the Corporate Insolvency Resolution Process (CIRP), which caused the suspension of trading and non-submission of results since FY22. This is a critical regulatory step toward potentially resuming trading on the BSE and NSE. Investors should remain cautious as the company's current financial health post-insolvency remains unquantified until these reports are released.
high confidence
What changedThe company is initiating the process to regularize its financial reporting after a multi-year hiatus caused by insolvency proceedings.
Why it mattersClearing the reporting backlog is the primary prerequisite for the company to apply for the resumption of trading and provides the first look at the business's viability post-restructuring.
Board Meeting Date: August 07, 2026Financial Years Covered: FY23, FY24, FY25Market Cap: Rs 7 CrPromoter Holding: 95.0%Debt: Rs 3 Cr
📅 Short termThe announcement is a positive procedural step, but since trading is suspended, there will be no immediate market price discovery.
📈 Long termIf the financials reveal a sustainable business model post-CIRP and trading resumes, it could mark a structural turnaround, though the low float remains a liquidity risk.
⚠ Risk flags
Trading suspension
Past insolvency (CIRP)
Multi-year reporting delay
Extremely low public float (5%)
👀 What to Watch
Monitor the outcome of the August 7 board meeting for the actual financial performance and any updates regarding the timeline for revocation of trading suspension.
Omkar Speciality Chemicals Approves Sale of Two Industrial Plots in Badlapur
The Board of Directors of Omkar Speciality Chemicals has approved the sale of two industrial properties in the MIDC Industrial Area, Badlapur. The assets include Plot No. W 83 (880 Sq. Mtrs.) and Plot No. W 93 (720 Sq. Mtrs.). This move appears to be part of an asset monetization or restructuring strategy, as the company's contact details suggest involvement in a Corporate Insolvency Resolution Process (CIRP). Investors should monitor the final sale value and how the proceeds are utilized for debt settlement.
Key Highlights
Approval for sale of Plot No. W 83 measuring 880 Sq. Mtrs. in MIDC Badlapur.Approval for sale of Plot No. W 93 measuring 720 Sq. Mtrs. in MIDC Badlapur.The decision was finalized in a Board Meeting held on June 25, 2026.Company contact information indicates ongoing CIRP (Insolvency) proceedings.
👀 What to Watch
Investors should exercise caution and wait for disclosures regarding the transaction value and the impact on the company's balance sheet. The potential insolvency context makes this a high-risk situation.
Omkar Speciality Chemicals Limited has released its financial results for the year ended March 31, 2026, following the implementation of an NCLT-approved Resolution Plan dated July 31, 2025. The auditors have issued an unmodified opinion but included an 'Emphasis of Matter' regarding the company's status as a 'Going Concern' and the significant restatement of assets and liabilities. The company reported a loss for the year, and the resolution process involved the extinguishment and reissuance of equity shares. Additionally, the company has failed to transfer ₹1.21 Lakhs in unclaimed dividends to the IEPF.
Key Highlights
NCLT approved the Resolution Plan on July 31, 2025, resulting in significant restatement of borrowings, trade payables, and equity.Auditors highlighted a 'Going Concern' uncertainty despite the implementation of the restructuring plan.The company failed to transfer ₹1.21 Lakhs of unpaid/unclaimed dividends from FY 2014-15 and FY 2015-16 to the Investor Education and Protection Fund (IEPF).The financial statements for the previous year (FY25) were audited by a different firm, Satya Prakash Natani & Co.Implementation of the plan included the infusion of funds by the Resolution Applicant and the restatement of certain assets.
👀 What to Watch
Investors should exercise caution as the company remains under a 'Going Concern' emphasis despite the resolution plan. Monitor the company's ability to generate operational cash flows and return to profitability post-restructuring.
Omkar Speciality Appoints Auditor; NCLT Approves Resolution Plan Amid Negative Net Worth
Omkar Speciality Chemicals has appointed M/s. Aabid & Co as Secretarial Auditor for FY 2025-26 following a board meeting on May 27, 2026. The company released delayed limited review reports for the first three quarters of FY 2025-26, noting that a Resolution Plan was approved by the NCLT on July 31, 2025. However, auditors have issued qualified conclusions due to the company's negative net worth and continued losses. Notably, comparative financial figures for FY 2024-25 are unavailable as the company failed to prepare results during its insolvency period.
Key Highlights
NCLT approved a Resolution Plan for the company on July 31, 2025, ending the CIRP phase.Auditors issued qualified conclusions for Q1, Q2, and Q3 of FY 2025-26 due to negative net worth.Financial results for the first three quarters of FY 2024-25 were not prepared, leaving no comparative data.M/s. Aabid & Co, Company Secretaries, appointed as Secretarial Auditor for the financial year 2025-26.The company continues to report losses, indicating material uncertainty regarding its status as a going concern.
👀 What to Watch
Investors should remain cautious as the company is in a high-risk recovery phase following insolvency. Monitor the successful implementation of the NCLT-approved resolution plan and the stabilization of financial reporting.
Omkar Speciality Chemicals Appoints Dipak Kumar Shaw as CEO; NCLT Resolution Plan Approved
Omkar Speciality Chemicals has appointed Mr. Dipak Kumar Shaw as the new CEO following a board meeting on May 27, 2026. The company recently emerged from the Corporate Insolvency Resolution Process (CIRP) with a resolution plan approved by the NCLT on July 31, 2025. However, the company continues to report losses and maintains a negative net worth, leading to a qualified opinion from auditors for the first three quarters of FY 2025-26. Financial results for the previous year (FY 2024-25) were not prepared, leaving investors without comparative performance data.
Key Highlights
Appointment of Mr. Dipak Kumar Shaw as Chief Executive Officer (CEO) effective May 27, 2026.Hon’ble NCLT approved the Resolution Plan for the company on July 31, 2025, ending the CIRP period.Auditors issued a qualified conclusion for Q1, Q2, and Q3 of FY 2025-26 due to negative net worth and material uncertainty.Comparative quarterly figures for FY 2024-25 are unavailable as results were not prepared during the insolvency process.Financial results are currently being prepared on a 'going concern' basis following the resolution plan approval.
👀 What to Watch
Investors should exercise extreme caution as the company is in a high-risk recovery phase post-insolvency. Monitor the new CEO's ability to stabilize operations and the company's progress in meeting the terms of the NCLT-approved resolution plan.
Omkar Speciality Chemicals has released financial results for the quarters ending June, September, and December 2025 following the NCLT's approval of its Resolution Plan on July 31, 2025. The auditors have issued a qualified opinion, highlighting that the company has a negative net worth and continues to incur losses, which creates material uncertainty regarding its status as a going concern. Additionally, comparative figures for the previous financial year (2024-25) are unavailable because the company did not prepare results while under the Corporate Insolvency Resolution Process (CIRP). While the approved plan provides a framework for recovery, the current financial position remains highly distressed.
Key Highlights
NCLT approved the company's Resolution Plan on July 31, 2025, ending the CIRP phase.Auditors issued a qualified conclusion due to negative net worth and persistent losses during the reviewed periods.Comparative financial data for the first three quarters of FY 2024-25 is missing as results were not prepared.Financial statements for June, September, and December 2025 were all signed off on May 27, 2026.Results were prepared on a going concern basis solely due to the subsequent approval of the resolution plan.
👀 What to Watch
Investors should avoid fresh positions until the company demonstrates operational stability and a clear path to positive net worth under the new resolution plan. The lack of comparative data and the qualified audit report make it difficult to assess the true pace of recovery.
Omkar Speciality Chemicals has released its delayed financial results for the first three quarters of FY 2025-26, revealing continued losses and a negative net worth. The company was under the Corporate Insolvency Resolution Process (CIRP) during the period, with a Resolution Plan finally approved by the NCLT on July 31, 2025. Auditors have issued a qualified opinion due to the lack of comparative figures from the previous year and significant uncertainty regarding the company's ability to continue as a going concern. These results were finalized significantly late, in May 2026, reflecting the administrative challenges during the insolvency process.
Key Highlights
Resolution Plan approved by Hon’ble NCLT on July 31, 2025, providing a potential path for recovery.Auditors issued a qualified conclusion citing negative net worth and material uncertainty over going concern status.No comparative quarterly figures available for FY 2024-25 as the company failed to prepare results for those periods.Company reported persistent losses across the quarters ended June, September, and December 2025.Financial results for all three quarters were delayed and only signed off by auditors on May 27, 2026.
👀 What to Watch
Investors should remain highly cautious as the company is in a fragile state with negative net worth and is only now emerging from insolvency. Closely monitor the execution of the NCLT-approved resolution plan and wait for stabilized financial reporting before considering any position.
Omkar Speciality Chemicals to Hold Monitoring Committee Meeting on May 27, 2026
Omkar Speciality Chemicals, currently under the Corporate Insolvency Resolution Process (CIRP), has scheduled a Monitoring Committee meeting for May 27, 2026. The committee will review and approve pending financial results for the quarters ended June, September, and December 2025. Key leadership appointments are on the agenda, including a new CEO and an Independent Director, alongside the reconstitution of essential board committees. This meeting marks a critical step in regularizing governance and financial reporting following the company's admission into CIRP in December 2022.
Key Highlights
Approval of unaudited financial statements for three consecutive quarters of 2025 (June, Sept, Dec).Appointment of Mr. Dipak Kumar Shaw as the Chief Executive Officer (CEO) of the company.Appointment of Mr. Ruhini Kumar Chakraborty as an Independent Director.Discussion regarding CIRP costs and the refund of Performance Bank Guarantees (PBG).Reconstitution of the Audit Committee and Stakeholder’s Relationship Committee.
👀 What to Watch
Investors should closely monitor the upcoming financial disclosures to assess the company's current valuation and operational state. Extreme caution is advised as the company remains under the insolvency resolution framework.
Omkar Speciality Chemicals to Reduce Share Capital to Nil Under Resolution Plan
Omkar Speciality Chemicals has announced a restructuring plan following its NCLT-approved resolution plan dated July 31, 2025. The plan involves reducing the entire existing share capital of the company to zero, effectively wiping out all current equity shareholders. Following this, fresh equity shares will be issued to the Resolution Applicant (RA) at a face value of INR 10, giving them 100% ownership. To meet SEBI's Minimum Public Shareholding requirements, the RA will later conduct an Offer for Sale (OFS) of 5% of the equity.
Key Highlights
Existing share capital to be reduced to NIL as per NCLT order dated July 31, 2025Resolution Applicant (RA) to be issued fresh equity shares at INR 10 face valueRA will hold 100% of the company's paid-up capital post-allotmentCompany to conduct a 5% Offer for Sale (OFS) to achieve Minimum Public ShareholdingThe company has been under Corporate Insolvency Resolution Process (CIRP) since December 5, 2022
👀 What to Watch
Current equity shareholders will lose their entire investment as the share capital is being reduced to zero. Investors should exercise extreme caution as existing shares will hold no value under the approved resolution plan.
Omkar Speciality to Cancel All Existing Shares on April 29; Appoints New CFO and CS
Omkar Speciality Chemicals is implementing its NCLT-approved Resolution Plan, which mandates the 100% cancellation of all existing promoter and public equity shares. The record date for this extinguishment is fixed for April 29, 2026, meaning current shareholders will lose their entire investment value. To facilitate the turnaround, the company is issuing 50 lakh new equity shares at ₹10 each to IFFAS Kshitij SPV LLP and raising a loan of up to ₹20 crore. New management, including a CFO and Company Secretary, has been appointed to lead the restructured entity.
Key Highlights
100% of existing promoter and public equity shares to be extinguished on the record date of April 29, 2026Issuance of 50,00,000 new equity shares at ₹10 each to IFFAS Kshitij SPV LLP for a total of ₹5 croreApproval to raise up to ₹20 crore via loan from Kshitij Polyline Limited as per the Resolution PlanAppointment of Mahendra Kumar Jain as Chief Financial Officer and Kuldeep Menaria as Company SecretaryResolution Plan implementation follows the NCLT Mumbai bench order dated July 31, 2025
👀 What to Watch
Existing shareholders should note that their equity holdings will be cancelled with zero value on April 29, 2026. Investors are advised to avoid the stock as the current equity is being completely wiped out under the IBC process.
Omkar Speciality Chemicals to Cancel Entire Share Capital; Record Date April 29, 2026
Omkar Speciality Chemicals has announced April 29, 2026, as the record date for the total extinguishment and cancellation of its existing paid-up share capital. This action is being taken pursuant to a Resolution Plan approved by the NCLT Mumbai bench on July 31, 2025, under the Insolvency and Bankruptcy Code. The cancellation applies to all equity shares of INR 10 each held by both the Promoters and the Public Shareholders. Consequently, existing equity holders will see their investment value reduced to zero as the shares are wiped out.
Key Highlights
Record date for share cancellation fixed as April 29, 2026.100% of equity shares held by Promoters and Public Shareholders will be extinguished.The move follows the NCLT order dated July 31, 2025, approving the Resolution Plan.Company has been under the Corporate Insolvency Resolution Process (CIRP) since December 5, 2022.
👀 What to Watch
Existing shareholders will lose their entire investment as the equity is being cancelled; investors should exit any remaining positions immediately if liquidity permits. The stock will likely be delisted or suspended following the capital extinguishment.
Omkar Speciality Chemicals Clarifies Record Date to be Fixed in April 15 Monitoring Committee Meet
Omkar Speciality Chemicals, which has been under the Corporate Insolvency Resolution Process (CIRP) since December 2022, has issued a clarification regarding its upcoming Monitoring Committee meeting. The company stated that April 15, 2026, will not be the record date as previously suggested, but rather the date on which the record date will be decided. The finalized record date will comply with regulatory requirements, ensuring a minimum gap of seven working days from the meeting date. This update is part of the ongoing resolution process overseen by the Monitoring Committee.
Key Highlights
Clarified that April 15, 2026, is the meeting date and not the record date for corporate actions.The revised record date will be determined during the Monitoring Committee meeting on April 15, 2026.The record date will maintain a mandatory minimum gap of 7 working days from the meeting date.Company remains under Corporate Insolvency Resolution Process (CIRP) since the December 5, 2022, order.
👀 What to Watch
Investors should monitor the outcome of the April 15 meeting for the finalized record date and details on the resolution plan. Due to the ongoing CIRP, the stock remains high-risk and subject to significant restructuring outcomes.
Omkar Speciality to Cancel All Existing Equity Shares; New ₹5 Cr Private Placement Planned
Omkar Speciality Chemicals is proceeding with its NCLT-approved Resolution Plan, which involves the total extinguishment of all existing promoter and public equity shares. A Monitoring Committee meeting on April 15, 2026, will finalize the record date for this cancellation, effectively wiping out current shareholders. Following the wipe-out, the company will issue 5,000,000 new equity shares at ₹10 each to raise ₹5 crore through a private placement. The company is also restructuring its leadership with the appointment of a new CFO and Company Secretary.
Key Highlights
100% extinguishment of all existing equity shares held by both Promoters and Public shareholdersRecord date for share cancellation to be determined at the Monitoring Committee meeting on April 15, 2026Issuance of 50,00,000 new equity shares at ₹10 each for an aggregate of ₹5,00,00,000Appointment of Mahendra Kumar Jain as CFO and Kuldeep Menaria as Company Secretary
👀 What to Watch
Existing equity holders will lose their entire investment as shares are being cancelled with zero value under the Resolution Plan. Investors should avoid the stock as current holdings will soon be extinguished.
⚠️How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI
⚡ Free FlashFinance Newsletters
AI-powered market intelligence in your inbox — completely free. Pick your topics; max 1 email per topic per day. Unsubscribe anytime.
✅ Everything below is 100% free — no payment, no card, ever.
🎉
You're subscribed!
A welcome email with your topics is on its way. Want it even faster? Join us on Telegram or WhatsApp:
